nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—Levomethadyl Acetate—CHRNB4—nicotine dependence	0.0183	0.212	CrCbGaD
Phenoxybenzamine—Methadyl Acetate—OPRM1—nicotine dependence	0.0166	0.192	CrCbGaD
Phenoxybenzamine—Methadone—CHRNA10—nicotine dependence	0.015	0.173	CrCbGaD
Phenoxybenzamine—Levomethadyl Acetate—CHRNA3—nicotine dependence	0.0127	0.147	CrCbGaD
Phenoxybenzamine—Levomethadyl Acetate—OPRM1—nicotine dependence	0.00722	0.0836	CrCbGaD
Phenoxybenzamine—Dextropropoxyphene—OPRM1—nicotine dependence	0.00624	0.0722	CrCbGaD
Phenoxybenzamine—Fentanyl—OPRM1—nicotine dependence	0.00618	0.0714	CrCbGaD
Phenoxybenzamine—Methadone—OPRM1—nicotine dependence	0.00424	0.049	CrCbGaD
Phenoxybenzamine—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00255	0.00284	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00254	0.00283	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00254	0.00283	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00254	0.00283	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—GABRA4—nicotine dependence	0.00252	0.00281	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00251	0.00279	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00247	0.00275	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00246	0.00274	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00246	0.00274	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00246	0.00274	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—GABRA4—nicotine dependence	0.00244	0.00272	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—GABRA4—nicotine dependence	0.00244	0.00272	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—CHRNB4—nicotine dependence	0.00242	0.00269	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00241	0.00268	CbGpPWpGaD
Phenoxybenzamine—CALM3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00239	0.00266	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00237	0.00264	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.00237	0.00264	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—CHRNB4—nicotine dependence	0.00234	0.00261	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—CHRNB4—nicotine dependence	0.00234	0.00261	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00233	0.0026	CbGpPWpGaD
Phenoxybenzamine—CALM1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00231	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00231	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—CHRNA5—nicotine dependence	0.00225	0.0025	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.00224	0.00249	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00223	0.00249	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00222	0.00247	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00219	0.00244	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—CHRNA5—nicotine dependence	0.00218	0.00242	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—CHRNA5—nicotine dependence	0.00218	0.00242	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00217	0.00242	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00215	0.00239	CbGpPWpGaD
Phenoxybenzamine—CALM3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00211	0.00235	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00209	0.00232	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00208	0.00231	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00207	0.00231	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00207	0.00231	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00204	0.00227	CbGpPWpGaD
Phenoxybenzamine—CALM2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00204	0.00227	CbGpPWpGaD
Phenoxybenzamine—CALM1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00204	0.00227	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.00203	0.00226	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00203	0.00226	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00203	0.00226	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00202	0.00224	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.002	0.00223	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00199	0.00222	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00198	0.0022	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00193	0.00215	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00193	0.00214	CbGpPWpGaD
Phenoxybenzamine—CALM3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00191	0.00213	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.00189	0.00211	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00188	0.0021	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00188	0.0021	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00185	0.00206	CbGpPWpGaD
Phenoxybenzamine—CALM1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00185	0.00206	CbGpPWpGaD
Phenoxybenzamine—CALM2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00185	0.00206	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.00185	0.00206	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00184	0.00205	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00184	0.00204	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00183	0.00204	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—CHRNA3—nicotine dependence	0.00183	0.00204	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00181	0.00202	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00181	0.00202	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00178	0.00198	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—CHRNA3—nicotine dependence	0.00177	0.00197	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—CHRNA3—nicotine dependence	0.00177	0.00197	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00175	0.00195	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00175	0.00195	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00174	0.00194	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00174	0.00194	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00173	0.00193	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.00172	0.00191	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00171	0.00191	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00171	0.0019	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00169	0.00188	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00168	0.00188	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00166	0.00184	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00165	0.00184	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00165	0.00183	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.00163	0.00182	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00163	0.00181	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—CHRNB2—nicotine dependence	0.00161	0.0018	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.0016	0.00178	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00158	0.00176	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00157	0.00175	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.00156	0.00174	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—CHRNB2—nicotine dependence	0.00156	0.00174	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—CHRNB2—nicotine dependence	0.00156	0.00174	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00155	0.00173	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00155	0.00172	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00153	0.0017	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00152	0.00169	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.0015	0.00167	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0015	0.00167	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.00148	0.00165	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00147	0.00164	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—CHRNA4—nicotine dependence	0.00147	0.00163	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.00145	0.00162	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00145	0.00161	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00142	0.00158	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—CHRNA4—nicotine dependence	0.00142	0.00158	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—CHRNA4—nicotine dependence	0.00142	0.00158	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.00141	0.00156	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.0014	0.00155	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00139	0.00155	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00135	0.00151	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00135	0.0015	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00135	0.0015	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.00133	0.00148	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00132	0.00147	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00132	0.00147	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.00129	0.00144	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00128	0.00143	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00126	0.0014	CbGpPWpGaD
Phenoxybenzamine—CALM2—cardiovascular system—nicotine dependence	0.00123	0.0807	CbGeAlD
Phenoxybenzamine—CALM1—cardiovascular system—nicotine dependence	0.00123	0.0803	CbGeAlD
Phenoxybenzamine—CALM3—midbrain—nicotine dependence	0.00123	0.0802	CbGeAlD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.0012	0.00134	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.0012	0.00133	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00119	0.00133	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00119	0.00133	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.00118	0.00132	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.00118	0.00131	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—cardiovascular system—nicotine dependence	0.00116	0.0757	CbGeAlD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.00112	0.00125	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00111	0.00124	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.0011	0.00123	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—FGD1—nicotine dependence	0.0011	0.00122	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.00109	0.00122	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—WASF2—nicotine dependence	0.00107	0.00119	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—FGD1—nicotine dependence	0.00106	0.00118	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—FGD1—nicotine dependence	0.00106	0.00118	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.00104	0.00115	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.00104	0.00115	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—WASF2—nicotine dependence	0.00103	0.00115	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—WASF2—nicotine dependence	0.00103	0.00115	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—WASF1—nicotine dependence	0.00103	0.00114	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—brain—nicotine dependence	0.00101	0.0661	CbGeAlD
Phenoxybenzamine—CALM2—Innate Immune System—WASF1—nicotine dependence	0.000992	0.0011	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—WASF1—nicotine dependence	0.000992	0.0011	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—brain—nicotine dependence	0.000988	0.0647	CbGeAlD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000978	0.00109	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000972	0.00108	CbGpPWpGaD
Phenoxybenzamine—CALM2—midbrain—nicotine dependence	0.000963	0.063	CbGeAlD
Phenoxybenzamine—CALM1—midbrain—nicotine dependence	0.000959	0.0627	CbGeAlD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000941	0.00105	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000936	0.00104	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000935	0.00104	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000924	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.000923	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000914	0.00102	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000908	0.00101	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000904	0.00101	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000881	0.000981	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000874	0.000973	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.000873	0.000972	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—midbrain—nicotine dependence	0.000861	0.0563	CbGeAlD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00086	0.000958	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.000859	0.000956	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.000857	0.000954	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.00085	0.000946	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000839	0.000934	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000825	0.000919	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000824	0.000918	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000822	0.000915	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKR1B10—nicotine dependence	0.000816	0.000909	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000815	0.000907	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000798	0.000888	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000798	0.000888	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000794	0.000884	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKR1B10—nicotine dependence	0.000789	0.000879	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKR1B10—nicotine dependence	0.000789	0.000879	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000781	0.00087	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000771	0.000858	CbGpPWpGaD
Phenoxybenzamine—CALM3—brain—nicotine dependence	0.000771	0.0504	CbGeAlD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000764	0.000851	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000763	0.00085	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000759	0.000845	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000749	0.000834	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—brain—nicotine dependence	0.000746	0.0488	CbGeAlD
Phenoxybenzamine—SLC22A3—brain—nicotine dependence	0.000713	0.0466	CbGeAlD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00071	0.00079	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000709	0.000789	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000696	0.000775	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000694	0.000773	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—midbrain—nicotine dependence	0.000687	0.0449	CbGeAlD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.000681	0.000758	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000677	0.000753	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000674	0.00075	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000668	0.000744	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FGD1—nicotine dependence	0.000647	0.00072	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000645	0.000718	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.000644	0.000717	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CYP2A7—nicotine dependence	0.000635	0.000707	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000632	0.000704	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000626	0.000697	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FGD1—nicotine dependence	0.000626	0.000697	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FGD1—nicotine dependence	0.000626	0.000697	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—WASF2—nicotine dependence	0.000623	0.000693	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000622	0.000692	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000618	0.000688	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CYP2A7—nicotine dependence	0.000615	0.000684	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CYP2A7—nicotine dependence	0.000615	0.000684	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000614	0.000684	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.000607	0.000675	CbGpPWpGaD
Phenoxybenzamine—CALM2—brain—nicotine dependence	0.000605	0.0396	CbGeAlD
Phenoxybenzamine—CALM1—brain—nicotine dependence	0.000602	0.0394	CbGeAlD
Phenoxybenzamine—CALM1—Immune System—WASF2—nicotine dependence	0.000602	0.000671	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—WASF2—nicotine dependence	0.000602	0.000671	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—WASF1—nicotine dependence	0.000597	0.000665	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000588	0.000655	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.000582	0.000647	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—WASF1—nicotine dependence	0.000578	0.000643	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—WASF1—nicotine dependence	0.000578	0.000643	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000574	0.000639	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.000574	0.000639	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000571	0.000636	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000569	0.000634	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000569	0.000634	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—brain—nicotine dependence	0.000568	0.0371	CbGeAlD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000565	0.000629	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.000558	0.000621	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.000556	0.000619	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000553	0.000615	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000553	0.000615	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000553	0.000615	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.00055	0.000613	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.000543	0.000605	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—brain—nicotine dependence	0.000541	0.0354	CbGeAlD
Phenoxybenzamine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000535	0.000595	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.000521	0.00058	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000513	0.000572	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000513	0.000571	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000502	0.000559	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000502	0.000559	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.000496	0.000552	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000475	0.000529	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.000469	0.000522	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000466	0.000519	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.000462	0.000514	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000455	0.000507	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000441	0.000491	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—brain—nicotine dependence	0.000432	0.0282	CbGeAlD
Phenoxybenzamine—CALM3—Signaling by GPCR—DRD2—nicotine dependence	0.000425	0.000474	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000423	0.000471	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—DRD2—nicotine dependence	0.000411	0.000458	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—DRD2—nicotine dependence	0.000411	0.000458	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.00041	0.000456	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—WASF2—nicotine dependence	0.000403	0.000448	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.000402	0.000448	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—WASF2—nicotine dependence	0.000389	0.000434	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—WASF2—nicotine dependence	0.000389	0.000434	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—WASF1—nicotine dependence	0.000386	0.00043	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000381	0.000424	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—WASF1—nicotine dependence	0.000373	0.000416	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—WASF1—nicotine dependence	0.000373	0.000416	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000363	0.000404	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.000358	0.000399	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—OPRM1—nicotine dependence	0.000348	0.000387	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000339	0.000377	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—OPRM1—nicotine dependence	0.000336	0.000374	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—OPRM1—nicotine dependence	0.000336	0.000374	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000334	0.000371	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000297	0.00033	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000296	0.00033	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000275	0.000307	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—DRD2—nicotine dependence	0.000251	0.00028	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—DRD2—nicotine dependence	0.000243	0.000271	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—DRD2—nicotine dependence	0.000243	0.000271	CbGpPWpGaD
